期刊文献+

抗幽门螺杆菌感染的中药治疗价值探索 被引量:16

Investigation into the value of Chinese medicine of anti-helicobacter pylori infection
原文传递
导出
摘要 [目的]筛选具有抗幽门螺杆菌(helicobacter pylori,HP)感染治疗价值的中药成分。[方法]摸索各中药成分的最低抑菌浓度,制备含有低于最低抑菌浓度中药提取液的HP的培养上清作用于Hela细胞,观察中药提取液对细胞空泡化的影响。[结果]各中药成分的最低抑菌浓度以黄连(0.39mg/ml)、厚朴(6.25mg/ml)、元胡(6.25mg/ml)最低,槟榔(25.00mg/ml)、黄柏(25.00mg/ml)、白芍(25.00mg/ml)等次之;药液作用后的细胞产生空泡的细胞的百分率以槟榔(8.0%)最低,厚朴(18.0%)次之。[结论]筛选到具有显著抑制细胞空泡化的中药成分为槟榔、厚朴,为临床治疗幽门螺杆菌感染提供了一种全新的思路。 [Objective]To select the segment of Chinese medicine which has the potential value of anti- helicobacter pylori (HP) infection. [Methods]Minimum inhibitory concentration (MIC) of segment of Chi- nese medicine was investigated. The extracting solution(lower than the MIC)of Chinese medicine,was add- ed to culture medium with HP, and then the effect on Hela cells was observed. Cells vacuolation was also observed, l-Results]The MIC of Coptis Chinensis, Cortex Magnoliae Officinalis and Corydalis Tuber was 0.39mg/ml,6.25mg/ml,6.25mg/ml respectively. The MIC of Betel Nut, Pellodendron and Radix Paeon- iae Alba was 25mg/ml. Cell vacuolation rate induced by Betel Nut was the least(8. 0%), that caused by cortex magnoliae officinalis was the second(18.0 %). l-Conclusion]We selected Chinese medicine Betel Nut and Cortex Magnoliae Officinalis, which could restrain the cell vacuolation. This would be a new way to treat HP infectional disease.
出处 《中国中西医结合消化杂志》 CAS 2013年第5期234-237,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 上海市黄浦区卫生局(No:2011-HGG-17)
关键词 幽门螺杆菌 中药 治疗价值 helicobacter pylori Chinese medicine value of curation
  • 相关文献

参考文献13

  • 1ARREN J R, MARSHALL B. Unidentified curved bacilli on gastric epilthelium in active chronicgastritis [J]. Lancet, 1983,18:1273--1275.
  • 2LUTHER J, CHEY W D, SAAD R J. A clinician's guide to salvage therapy for persistent Helicobacter pylori infection[J]. Hosp Pract (Minneap), 2011,39 : 133-- 140.
  • 3MEINE G C, ROTA C, DIETZ J, et al. Relationship between cagA--positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil [J].Arq Gastroenterol, 2011,48 : 41 --45.
  • 4COVER T L, BLASER M J. Purification and charac- terization of the vacuolating toxinffom Helicobacter pylori[J]. Biol. Chem, 1992,267 : 10570-- 10575.
  • 5KUCK D, KOLMERER B, LKING-KONERT C, et al, Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS [J]. Infect Immun, 2001,69 : 5080- 5087.
  • 6DE BERNARD M, MOSCHIONI M, NAPOLITAN- IG,et al. The Vac A toxin of HeIicohaeter pyIori iden- tifies a new intermediate filament-interacting protein [J]. EMBO, 2000,19: 48-- 56.
  • 7ROMANO M,IOVENE M R,RUSSO M I,et al. Fail- ure of first-line eradication treatment significantly in- creases prevalence of antimicrobial-resistant helico- bacter pylori clinical isolates[J].Clin Pathol, 2008,61: 1112--1115.
  • 8LOCHMANNOVA'. Current perspective of the re- sistance of Helicobacter pylori strains to antimicrobial drugs[J]. Klin Mikrobiol Infekc Lek, 2010, 16: 199-- 202.
  • 9王建平,彭孝纬.单味中药治疗幽门螺杆菌的动物研究[J].胃肠病学和肝病学杂志,2010,19(4):345-347. 被引量:55
  • 10黄浩然,陈蔚文,徐晖.中药及其有效成分抑制幽门螺杆菌的研究进展[J].中药新药与临床药理,2008,19(6):508-511. 被引量:38

二级参考文献63

共引文献91

同被引文献246

引证文献16

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部